S

Sosei Heptares

162 employees

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Novel Medicines
Pre-Clinical
Pharmaceutical
Drug Discovery
Structure-Based Drug Design platform capabilities
Computational Chemistry
Neurology
Chemistry
Immunology
Molecular Pharmacology
Therapeutics
Gastroenterology
Development
Inflammatory
GPCR

Date founded

1990

Funding rounds raised

Total raised

$30M

from 7 investors over 7 rounds

S

Sosei Heptares raised $5M on May 18, 2017

Investors: Teva UK Limited

S

Sosei Heptares raised $21M on June 27, 2013

Investors: Takeda UK Limited, The Stanley Foundation and Clarus Ventures, LLC

S

Sosei Heptares raised $30M on February 24, 2009

Investors: MVM Partners and Clarus Ventures, LLC

S

Sosei Heptares raised undisclosed on August 10, 2007

Investors: MVM Partners

FAQ